Hye Ryun Kim

18.2k citations
346 papers · 11.0k · 3 hit papers · h-index 49

Impact in

  • Oncology top 0.2%
    • Lung Cancer Research Studies
    • Cancer Immunotherapy and Biomarkers
    • Colorectal Cancer Treatments and Studies
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment
    • Brain Metastases and Treatment

Papers in

    • Lung Cancer Treatments and Mutations 100
    • Cancer Immunotherapy and Biomarkers 40
    • Lung Cancer Research Studies 34
    • Pancreatic and Hepatic Oncology Research 15
    • Colorectal Cancer Treatments and Studies 13

Hye Ryun Kim

328 papers receiving 10.8k citations

Hye Ryun Kim's Hit Papers

Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study 2020 · 514 citations
5140+3+6Years since publication50010001.5k2.0k

Peers

Hye Ryun Kim
Comparison fields: 5 of 171
  • Oncology 4.6k
  • Pulmonary and Respiratory Medicine 5.0k
  • Cancer Research 1.3k
  • Otorhinolaryngology 197
  • Immunology 924
Replace David I. Quinn with:
David I. Quinn United States
Taylor Murray United States
Roy M. Bremnes Norway
Taofeek K. Owonikoko United States
Carlos Camps Spain
Xuelei Ma China
Gerold Bepler United States
Anish Thomas United States
Sun Young Rha South Korea
Martin J. Edelman United States
Hye Ryun Kim relative to David I. Quinn United States David I. Quinn's profile →
Citations per field
00.5×1.7×
David I. Quinn · 1×
Citations per year

Countries citing papers authored by Hye Ryun Kim

Since Specialization
Citations

This map shows the geographic impact of Hye Ryun Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hye Ryun Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hye Ryun Kim more than expected).

Fields of papers citing papers by Hye Ryun Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hye Ryun Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hye Ryun Kim. The network helps show where Hye Ryun Kim may publish in the future.

Co-authors

The 25 scholars most cited alongside Hye Ryun Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hye Ryun Kim Line = papers co-authored together Hye Ryun Kim links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 346 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
Hit paper breakdown →
20162453
2
Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study
Hit paper breakdown →
2020514
3
CNS Efficacy of Osimertinib in Patients With T790M-Positive Advanced Non–Small-Cell Lung Cancer: Data From a Randomized Phase III Trial (AURA3)
Hit paper breakdown →
2018364
4 2017241
5 2016216
6 2005160
7 2020156
8 2008149
9 2021142
10 2012141
11 2020139
12 2016127
13 2016124
14 2022119
15 2011118
16 2020113
17 2022112
18 2019103
19 2013102
20 201999

About Hye Ryun Kim

Hye Ryun Kim is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Immunology and Surgery, having authored 346 papers that have together received 11.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (100 papers), Cancer Immunotherapy and Biomarkers (40 papers), Lung Cancer Research Studies (34 papers), Head and Neck Cancer Studies (25 papers), Food Quality and Safety Studies (21 papers), Cancer Genomics and Diagnostics (18 papers), Pancreatic and Hepatic Oncology Research (15 papers) and Colorectal Cancer Treatments and Studies (13 papers). The work is most often cited by research in Oncology (4.6k citations), Pulmonary and Respiratory Medicine (5.0k citations), Cancer Research (1.3k citations), Otorhinolaryngology (197 citations) and Immunology (924 citations). Hye Ryun Kim has collaborated with scholars based in South Korea, United States and Taiwan. Frequent co-authors include Byoung Chul Cho, Myung‐Ju Ahn, Min Hee Hong, Hyo Sup Shim, Yi‐Long Wu, Vassiliki A. Papadimitrakopoulou, Tony Mok, Marina Chiara Garassino, Sang‐Jun Ha and Hiroaki Akamatsu. Their work appears in journals such as Annals of Oncology, Lung Cancer, Journal of Clinical Oncology, Journal of Thoracic Oncology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact